General
Preferred name
PROBUCOL
Synonyms
Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole ()
DH-581 ()
Probucol ()
Panavir ()
Lurselle ()
Lorelco ()
NSC-86225 ()
Sinlestal ()
Bisbid ()
NSC-652160 ()
P&D ID
PD001899
CAS
23288-49-5
Tags
available
drug
Approved by
FDA
First approval
1977
Drug indication
Coronary artery disease
Diabetic nephropathy
Drug Status
approved
investigational
withdrawn
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Probucol is a lipid-lowering drug. Marketing of this drug was ceased in 1995 in the US due to safety concerns. (GtoPdb)
PHARMACODYNAMICS Probucol lowers cholesterol levels by increasing LDL (low-density lipoprotein) breakdown. Additionally, probucol may inhibit cholesterol synthesis and delay cholesterol absorption. Probucol is a powerful antioxidant drug normally used to prevent vascular disease caused by the free radicals in the body.
MOA Probucol lowers serum cholesterol by increasing the fractional rate of low-density lipoprotein (LDL) catabolism in the final metabolic pathway for cholesterol elimination from the body. This drug may also act to inhibit the initial stages of cholesterol synthesis and act to inhibit the absorption of cholesterol from the diet. Recent information suggests that probucol may inhibit the oxidation and tissue deposition of LDL cholesterol, thereby inhibiting atherogenesis. It appears to inhibits ABCA1-mediated cellular lipid efflux.
DESCRIPTION Probucol (DH-581) is an anti-hyperlipidemic agent. Probucol activates glutathione peroxidase. Probucol promotes low density lipoprotein (LDL) catabolism, inhibits ABCA1-dependent cholesterol efflux, and decreases HDL-C levels. Probucol also has anti-inflammatory, antioxidant and neuroprotective properties. Probucol can be used for researches on bone, cardiovascular, cancer, neurological, and metabolism-related diseases[1][2][3][4][5][6][7][8][9][10][11][12][13].
PRICE 29
DESCRIPTION Probucol is a potent antioxidant that inhibits the oxidation of cholesterol in low-density lipoprotein, which prevents the formation of macrophage-derived foam cells that lead to atherosclerotic vascular lesions. Probucol is an anti-hyperlipidemic drug, used to lower LDL and HDL cholesterol. (Enamine Bioactive Compounds)
DESCRIPTION Selective non-transportable GlyT1 inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION Enhances selective uptake of HDL-associated cholesteryl esters. (BOC Sciences Bioactive Compounds)
DESCRIPTION Probucol (DH-581), an anti-hyperlipidemic drug, can lower the level of cholesterol in the bloodstream by increasing the LDL catabolic rate. (TargetMol Bioactive Compound Library)
Cell lines
2
Organisms
2
Compound Sets
35
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Withdrawn 2.0
External IDs
69
Properties
(calculated by RDKit )
Molecular Weight
516.31
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
9.91
TPSA
40.46
Fraction CSP3
0.61
Chiral centers
0.0
Largest ring
6.0
QED
0.31
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
ATP-binding cassette transporter blocker
Inhibitor
Antioxidants
ABCA1-mediated cellular lipid efflux inhibitor
Serine Protease Hepsin Inhibitors
atherogenesis inhibitor
Target
ATP-binding cassette sub-family A member 1
ABCA1
CES1
Virus Protease
ABCA1, ABCB11, CES1
LDL
Caspase
Glutathione Peroxidase
Reactive Oxygen Species (ROS)
Reactive Oxygen Species
Primary Target
Multidrug Transporters
Member status
member
Indication
coronary artery disease (CAD)
ATC
C10AX02
Pathway
Membrane Transporter/Ion Channel
Anti-infection
Apoptosis
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
NF-¦ÊB
Therapeutic Class
Anticholesteremic Agents
Solubility
In vitro:<br/>10 mM in DMSO
Source data